Search research articles
Contact Us
Filters
Showing results (521-530 of 918) with videos related to
Page
of 92
Sort By:
JAMA Network Open
|
July 7, 2022
Association of Allostatic Load With Overall Mortality Among Patients With Metastatic Non-Small Cell Lung Cancer
Samilia Obeng-Gyasi, Yaming Li, William E Carson, et al.
Brain : a Journal of Neurology
|
May 12, 2012
Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome
Alicja Lerner, Anto Bagic, Janine M Simmons, et al.
Psycho-Oncology
|
October 19, 2018
Pilot randomized controlled trial of a symptom cluster intervention in advanced cancer
Sharla M Wells-Di Gregorio, Donald R Marks, Joseph DeCola, et al.
Neuroimage
|
January 23, 2017
Regional and source-based patterns of [<sup>11</sup>C]-(+)-PHNO binding potential reveal concurrent alterations in dopamine D<sub>2</sub> and D<sub>3</sub> receptor availability in cocaine-use disorder
Patrick D Worhunsky, David Matuskey, Jean-Dominique Gallezot, et al.
Neurology
|
March 12, 2003
PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy
M T Toczek, R E Carson, L Lang, et al.
Molecular Psychiatry
|
June 17, 2021
In vivo evidence of lower synaptic vesicle density in schizophrenia
Rajiv Radhakrishnan, Patrick D Skosnik, Mohini Ranganathan, et al.
Psychoneuroendocrinology
|
September 18, 2020
Within-person changes in cancer-related distress predict breast cancer survivors' inflammation across treatment
Megan E Renna, M Rosie Shrout, Annelise A Madison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2002
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661
Gini F Fleming, Neal J Meropol, Gary L Rosner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 29, 2025
Associations between fluid biomarkers and PET imaging ([11C]UCB-J) of synaptic pathology in Alzheimer's disease
Johanna Nilsson, Adam P Mecca, Nicholas J Ashton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients
Robin Parihar, Padma Nadella, Adrian Lewis, et al.
Page
of 92
Search research articles
Search
Showing results (521-530 of 918) with videos related to
Sort By:
Page
of 92
JAMA Network Open
|
July 7, 2022
Association of Allostatic Load With Overall Mortality Among Patients With Metastatic Non-Small Cell Lung Cancer
Samilia Obeng-Gyasi, Yaming Li, William E Carson, et al.
Brain : a Journal of Neurology
|
May 12, 2012
Widespread abnormality of the γ-aminobutyric acid-ergic system in Tourette syndrome
Alicja Lerner, Anto Bagic, Janine M Simmons, et al.
Psycho-Oncology
|
October 19, 2018
Pilot randomized controlled trial of a symptom cluster intervention in advanced cancer
Sharla M Wells-Di Gregorio, Donald R Marks, Joseph DeCola, et al.
Neuroimage
|
January 23, 2017
Regional and source-based patterns of [<sup>11</sup>C]-(+)-PHNO binding potential reveal concurrent alterations in dopamine D<sub>2</sub> and D<sub>3</sub> receptor availability in cocaine-use disorder
Patrick D Worhunsky, David Matuskey, Jean-Dominique Gallezot, et al.
Neurology
|
March 12, 2003
PET imaging of 5-HT1A receptor binding in patients with temporal lobe epilepsy
M T Toczek, R E Carson, L Lang, et al.
Molecular Psychiatry
|
June 17, 2021
In vivo evidence of lower synaptic vesicle density in schizophrenia
Rajiv Radhakrishnan, Patrick D Skosnik, Mohini Ranganathan, et al.
Psychoneuroendocrinology
|
September 18, 2020
Within-person changes in cancer-related distress predict breast cancer survivors' inflammation across treatment
Megan E Renna, M Rosie Shrout, Annelise A Madison, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 11, 2002
A phase I trial of escalating doses of trastuzumab combined with daily subcutaneous interleukin 2: report of cancer and leukemia group B 9661
Gini F Fleming, Neal J Meropol, Gary L Rosner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association
|
August 29, 2025
Associations between fluid biomarkers and PET imaging ([11C]UCB-J) of synaptic pathology in Alzheimer's disease
Johanna Nilsson, Adam P Mecca, Nicholas J Ashton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
August 7, 2004
A phase I study of interleukin 12 with trastuzumab in patients with human epidermal growth factor receptor-2-overexpressing malignancies: analysis of sustained interferon gamma production in a subset of patients
Robin Parihar, Padma Nadella, Adrian Lewis, et al.
Page
of 92